MET and neoplasm: In addition, the ultra-long tumor retention time combined with its strong c-Met targeting ability allowed the nanoparticles to highly selectively accumulate at the site of hepatic metastases and maintain a certain duration (at least 7 days) to monitor the efficacy of the therapy [59].